PlainPatent
USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Janssen Sciences Ireland UC

USPTO PatentsView assignee record — 111 granted patents across 10 technology areas, active 2015–2024. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS).

Explore the portfolio See the ranking
111
Total patents granted
10
CPC technology areas
12.5
Avg claims per patent
-82%
5-year filing velocity

The verdict

Janssen holds 111 US patents across 10 technology areas — rank #3,349 of 50,000 tracked assignees.

#3,349
of 50,000 US assignees by volume
Top 49%
by Innovation Score (35.6/100)
12.5
avg claims per patent
-82%
filing velocity, last 5 yrs

Portfolio overview

Janssen Sciences Ireland UC has been granted 111 US utility patents between 2015 and 2024, placing Janssen Sciences Ireland UC at rank #3,349 across all assignees tracked by PlainPatent. This portfolio spans 10 distinct Cooperative Patent Classification (CPC) subclasses, averaging 12.5 claims per patent with primary concentration in A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS). As a Foreign Corporation, Janssen Sciences Ireland UC is one of the more focused assignees in the PatentsView dataset. The composite Innovation Score of 35.6/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 17 grants, compared with 94 in the 2015–2019 window — a -82% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Janssen Sciences Ireland UC's 12.5 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 10 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Janssen Sciences Ireland UC against peers pursuing similar technology classes.

How does Janssen compare?

Granted US patents 2015–2025 versus the largest corporate holders — this company marked ◀

patents

What this shows Janssen holds 111 patents — placing it at rank #3,349 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.

Source USPTO PatentsView — granted utility patents As of 2015–2025

Janssen's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

36 Top 49% higher than 51% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). Below this entry. 30–40: 15,294 US assignees (31%). This entry sits in this band. 40–50: 11,491 US assignees (23%). Above this entry. 50–60: 5,058 US assignees (10%). Above this entry. 60–70: 1,537 US assignees (3%). Above this entry. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView — PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2024

-100102030 201520162017201820192020202120232024 1
USPTO utility patent grants by year · 2015–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Janssen Sciences Ireland UC patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 10 9.0%
2016 24 21.6%
2017 20 18.0%
2018 24 21.6%
2019 16 14.4%
2020 9 8.1%
2021 5 4.5%
2023 2 1.8%
2024 1 0.9%

Which technologies does Janssen Sciences Ireland UC patent most?

Top 10 of 10 technology areas

Patent Moat Analysis

Portfolio Volume Moderate
Tech Breadth Focused
Claim Depth Standard
Velocity Declining

Where it ranks

Overall rank by patents

#3,349

Across all tracked assignees

Innovation Score

35.6 out of 100

View all rankings →

Data Source

USPTO PatentsView — US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Janssen Sciences Ireland UC hold?
Janssen Sciences Ireland UC holds 111 US granted patents filed between 2015 and 2024, spanning 10 technology areas.
What is Janssen Sciences Ireland UC's Innovation Score?
Janssen Sciences Ireland UC has an Innovation Score of 35.6 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Janssen Sciences Ireland UC focus on?
Janssen Sciences Ireland UC's top technology area is A61P (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS) with 108 patents. The company has filed patents in 10 CPC subclasses total.
Is Janssen Sciences Ireland UC's patent filing rate increasing or decreasing?
Janssen Sciences Ireland UC's recent filing velocity is -82% compared to the prior five-year period. Filing activity has slowed relative to earlier years.
What does claim depth mean for Janssen Sciences Ireland UC's patents?
Janssen Sciences Ireland UC's patents average 12.5 claims each. This falls within the standard range, providing solid legal coverage.
How is the Janssen Sciences Ireland UC patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

Learn More

How Innovation Score Works

Understand the four dimensions behind the composite score
How to Read Patent Data

Plain-English guide to CPC codes, claims, and metrics
Patent Moat Analysis

How companies use patents as competitive barriers

Explore the patent dataset

A61P technology

Janssen Sciences Ireland UC's primary CPC class — all holders and yearly trends
Top 50 patent holders

See where Janssen Sciences Ireland UC ranks among the largest US patent assignees
All technology classes

Browse every CPC technology area by patent activity
How the score works

The four dimensions behind the Innovation Score

Related

All companies → | All technologies → | Rankings →
Data sourced from USPTO PatentsView — official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology — how this data is sourced, computed, and verified.

All federal data sources used on this page
  • USPTO PatentsView — official U.S. Patent and Trademark Office bulk patent data. patentsview.org
  • USPTO Patent Application Information Retrieval (PAIR) — application status and file history. uspto.gov/patents/pair
  • USPTO Bulk Data Storage System — comprehensive patent text + claims dataset. bulkdata.uspto.gov
  • USPTO CPC Classification — Cooperative Patent Classification scheme for technology categorization. uspto.gov/cpc
  • SEC EDGAR — public filings cross-reference for assignee corporate entity matching. sec.gov/edgar
  • WIPO PATENTSCOPE — international patent context (related international filings). wipo.int/patentscope